文献速递临床试验与 GCP真实世界研究与卫生经济

LOFIT(生活方式前置办公室用于将生活方式医学整合到患者治疗中):一种面向社区生活方式改变选择的新型照护模式——研究方案

LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients): a novel care model towards community-based options for lifestyle change-study protocol.
PubMed 文献 · Trials · 2023-02-17

LOFIT研究采用两项平行实用随机对照试验,在荷兰三家门诊招募BMI≥25 kg/m²和/或吸烟的患者,随机分为生活方式经纪人面对面动机性访谈 coaching 并转介社区生活方式干预的干预组与常规照护对照组,计划共纳入552例,主要结局为改编版Fuster-BEWAT复合健康风险与生活方式评分,随访至12个月。

要点

  • 干预由生活方式经纪人以面对面动机性访谈形式开展,并将患者引导至社区生活方式干预。
  • 主要结局为改编版Fuster-BEWAT复合健康风险与生活方式评分。
  • 计划共纳入552例患者,每项试验276例,分入两个治疗组。

核心结论

  • 本研究旨在深入了解这种新型照护模式的(成本)效果,该模式将接受二级或三级照护的患者转介至社区生活方式干预以改变其生活方式。

研究设计与样本

  • 开展两项平行实用随机对照试验,分别针对(心)血管疾病(即(有)心血管疾病风险、糖尿病)和肌肉骨骼疾病(即骨关节炎、髋或膝关节假体)。
  • 从荷兰三家门诊邀请患者参与研究,纳入标准为体重指数(BMI)≥25 kg/m²和/或吸烟。
  • 参与者被随机分配至干预组或常规照护对照组,计划共纳入552例患者,每项试验276例,分入两个治疗组。
  • 干预组患者与所谓的生活方式经纪人进行面对面动机性访谈(MI)辅导,并被支持和引导至合适的社区生活方式干预。
  • 使用网络沟通平台在生活方式经纪人、患者、被转介的社区生活方式干预和/或其他相关利益方(如全科医生)之间进行沟通。

主要发现

  • 主要结局指标为改编版Fuster-BEWAT,即由静息收缩压和舒张压、客观测量的体力活动和静坐时间、BMI、水果和蔬菜摄入量以及吸烟行为组成的复合健康风险与生活方式评分。
  • 次要结局包括心脏代谢标志物、人体测量学指标、健康行为、心理因素、患者报告结局测量(PROMs)、成本效果测量以及混合方法过程评价。
  • 数据收集在基线、3、6、9和12个月随访时进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A healthy lifestyle is indispensable for the prevention of noncommunicable diseases. However, lifestyle medicine is hampered by time constraints and competing priorities of treating physicians. A dedicated lifestyle front office (LFO) in secondary/tertiary care may provide an important contribution to optimize patient-centred lifestyle care and connect to lifestyle initiatives from the community. The LOFIT study aims to gain insight into the (cost-)effectiveness of the LFO. METHODS: Two parallel pragmatic randomized controlled trials will be conducted for (cardio)vascular disorders (i.e. (at risk of) (cardio)vascular disease, diabetes) and musculoskeletal disorders (i.e. osteoarthritis, hip or knee prosthesis). Patients from three outpatient clinics in the Netherlands will be invited to participate in the study. Inclusion criteria are body mass index (BMI) ≥25 (kg/m2) and/or smoking. Participants will be randomly allocated to either the intervention group or a usual care control group. In total, we aim to include 552 patients, 276 in each trial divided over both treatment arms. Patients allocated to the intervention group will participate in a face-to-face motivational interviewing (MI) coaching session with a so-called lifestyle broker. The patient will be supported and guided towards suitable community-based lifestyle initiatives. A network communication platform will be used to communicate between the lifestyle broker, patient, referred community-based lifestyle initiative and/or other relevant stakeholders (e.g. general practitioner). The primary outcome measure is the adapted Fuster-BEWAT, a composite health risk and lifestyle score consisting of resting systolic and diastolic blood pressure, objectively measured physical activity and sitting time, BMI, fruit and vegetable consumption and smoking behaviour. Secondary outcomes include cardiometabolic markers, anthropometrics, health behaviours, psychological factors, patient-reported outcome measures (PROMs), cost-effectiveness measures and a mixed-method process evaluation. Data collection will be conducted at baseline, 3, 6, 9 and 12 months follow-up. DISCUSSION: This study will gain insight into the (cost-)effectiveness of a novel care model in which patients under treatment in secondary or tertiary care are referred to community-based lifestyle initiatives to change their lifestyle. TRIAL REGISTRATION: ISRCTN ISRCTN13046877 . Registered 21 April 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van Dijk ML, Te Loo LM, Vrijsen J, et al. LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients): a novel care model towards community-based options for lifestyle change-study protocol. Trials. 2023. PMID: 36803271. doi:10.1186/s13063-022-06960-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。